Ben Collins asks whether we are seeing the end of the purchaser-provider split as we know it.
Tom Buckley considers key policy changes in the two years since the publication of the NHS five year forward view, looking at the progress made and the challenges that lie ahead.
Ruth Robertson outlines the importance of involving GPs in commissioning and planning in the NHS if we are to meet the challenges of transforming care and balancing finances.
Clinical commissioning is changing in response to financial and operational pressures, and the implementation of new care models. Chris Ham considers whether strategic commissioning is the way forward.
How are new co-commissioning arrangements progressing, a year after their introduction? Chris Naylor considers the results of our survey of GP practices in six clinical commissioning groups, carried out with the Nuffield Trust.
Are conflicts of interest affecting the services patients receive? Or is this inherent feature of clinical commissioning being managed appropriately through common-sense decision-making?
Is the ‘purchaser–provider split’ dead? No. Is it dying? Quite possibly, says Nicholas Timmins.
Although the ambitions of the care models in the US may resonate with our intentions here, we would be wise to learn from the early experiences of those who went before us, says Rachael Addicott.
One year ago today, clinical commissioning groups formally took on their statutory responsibility for £65 billion of the NHS budget. So how do individuals in CCGs feel about engagement now?